Official websites use .gov

A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS

A lock ( 🔒 ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

Need Help

G0S2 and lipid metabolism in the regulation of hematopoietic development

Award Number: R15HL172157
ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE
OPDIV: NIH
AWARD CLASS: DISCRETIONARY
AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)
PERIOD OF PERFORMANCE START DATE: 02/01/2024
PERIOD OF PERFORMANCE END DATE: 09/01/2024

Group Awards By:

View Award Description

G0S2 and lipid metabolism in the regulation of hematopoietic development - PROJECT SUMMARY/ABSTRACT The long-term goals of this proposal are two-fold: (i) understand the functional role of G0/G1 switch gene 2 (G0S2) during normal and obese hematopoiesis, and (ii) leverage that understanding for the development of new therapeutics to treat multiple obesity-related conditions. The prevalence of obesity in the United States has tripled over the past several decades, which has tremendous effects on overall health. Chronic inflammation, due to the overproduction of myeloid cells from hematopoietic stem cells (HSCs) of the bone marrow, is an established mechanism explaining the negative health impacts of obesity. Hematopoiesis is the process of blood cell production by HSCs residing in the bone marrow. Energy metabolism has emerged as an important regulator of HSC fate. Lipid metabolism, primarily fatty acid oxidation (FAO), was shown to aid in HSC self-renewal and differentiation. One important regulator of lipid metabolism is G0S2, a small 11 kDa protein that regulates multiple cellular functions, including intracellular lipolysis and oxidative phosphorylation. G0S2 contributes to triglyceride accumulation both indirectly through inhibition of lipolysis in adipose and liver tissue, and also directly through lysophosphatidic acyl transferase (LPAAT) enzymatic activity. However, while much is known about the role of G0S2 in highly metabolic cells, its role in normal blood cell development is unknown. We hypothesize that G0S2 LPAAT activity regulates lipid and energy during normal myeloid development. Specific Aim 1: Test the hypothesis that G0S2 regulates neutrophil development and function in normal but not obese mice. Utilizing mice maintained on a normal- versus high-fat-diet, we will assess the effects of altered G0S2 expression on the differentiation of murine HSCs in response to granulocyte-colony stimulating factor (G-CSF) both ex vivo and in vivo. We will utilize wild-type versus G0S2 knockout mice, and will test for differences comparing male versus female mice. Specific Aim 2: Test the hypothesis that G0S2 LPAAT activity contributes to myeloid development. We will investigate whether G0S2 LPAAT activity contributes to survival or differentiation of hematopoietic stem and progenitor cells. We will utilize bone marrow from G0S2 knockout mice for ectopic expression of wild-type versus mutant forms of murine G0S2. Resulting cells will be assessed for phenotypic changes both ex vivo and in vivo. We have formed a collaborative research team to rigorously establish the mechanistic role of G0S2 during myeloid development. Additionally, this R15 project will provide a unique training opportunity for graduate students in our MSc program. Texas Tech University Health Sciences Center at El Paso is a Title V Hispanic-Serving Institution located along the U.S./Mexico border, with a majority of our population identifying as Hispanic. This R15 will enhance the ability of our students to prepare for future jobs as research assistants, and will help them compete successfully for admission into MD and/or PhD education programs. Successful completion of the proposed experiments will be crucial for understanding the role of G0S2 and lipid metabolism during normal blood cell development, and will promote the careers of young minority students.


Issue Date FY	Funding FY	Legal Entity Name	Legal Entity Address	Legal Entity City	Legal Entity State	Legal Entity Zip Code	Legal Entity COUNTY	Legal Entity COUNTRY	Assistance Listing	Award Code	Budget Year	Action Date	Action Type	Action Amount

Issue Date FY: 2025 ( Subtotal = -$428,261 )
2025	2024	TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER AT EL PASO	130 RICK FRANCIS ST	EL PASO	TX	79905	EL PASO	USA	Blood Diseases and Resources Research	001	1	5/6/2025	NEW	-$428,261
2025	2024	TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER AT EL PASO	130 RICK FRANCIS ST	EL PASO	TX	79905	EL PASO	USA	Blood Diseases and Resources Research	000	1	4/25/2025	NEW	$0
														Subtotal = -$428,261

Issue Date FY: 2024 ( Subtotal = $480,000 )
2024	2024	TEXAS TECH UNIVERSITY HEALTH SCIENCES CENTER AT EL PASO	5001 EL PASO DR	EL PASO	TX	79905	EL PASO	USA	Blood Diseases and Resources Research	000	1	1/26/2024	NEW	$480,000
														Subtotal = $480,000

Grand Total All Awards = $51,739

Top

All Categories

About

Search

Reports

Data Submission

Award Information

G0S2 and lipid metabolism in the regulation of hematopoietic development

Award Number: R15HL172157

ORGANIZATION: NATIONAL HEART, LUNG, & BLOOD INSTITUTE

OPDIV: NIH

AWARD CLASS: DISCRETIONARY

AWARD ACTIVITY TYPE: SCIENTIFIC/HEALTH RESEARCH (INCLUDES SURVEYS)

PERIOD OF PERFORMANCE START DATE: 02/01/2024

PERIOD OF PERFORMANCE END DATE: 09/01/2024

Federal Websites

Department of Health & Human Services

HHS Operating Divisions

HHS Staff Divisions

Download A Document Viewer